SkyOak Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6M Buy
16,314
+109
+0.7% +$111K 3.2% 8
2026
Q1
$14.9M Sell
16,205
-509
-3% -$516K 2.73% 8
2025
Q4
$18M Sell
16,714
-1,168
-7% -$1.12M 3.23% 6
2025
Q3
$13.6M Sell
17,882
-428
-2% -$319K 2.58% 8
2025
Q2
$14.3M Sell
18,310
-74
-0.4% -$57.5K 2.87% 8
2025
Q1
$15.2M Sell
18,384
-581
-3% -$483K 3.33% 6
2024
Q4
$14.6M Sell
18,965
-499
-3% -$413K 3.13% 6
2024
Q3
$17.2M Sell
19,464
-513
-3% -$461K 3.82% 6
2024
Q2
$18.1M Sell
19,977
-2,578
-11% -$2.06M 4.22% 4
2024
Q1
$17.5M Sell
22,555
-1,884
-8% -$1.34M 4.2% 3
2023
Q4
$14.2M Sell
24,439
-873
-3% -$510K 3.71% 6
2023
Q3
$13.6M Sell
25,312
-343
-1% -$177K 3.97% 4
2023
Q2
$12M Sell
25,655
-3,825
-13% -$1.6M 3.4% 5
2023
Q1
$10.1M Buy
29,480
+472
+2% +$159K 3.09% 5
2022
Q4
$10.6M Sell
29,008
-963
-3% -$341K 3.57% 4
2022
Q3
$9.69M Sell
29,971
-711
-2% -$225K 3.47% 3
2022
Q2
$9.95M Sell
30,682
-486
-2% -$146K 3.4% 3
2022
Q1
$8.93M Sell
31,168
-591
-2% -$152K 2.48% 5
2021
Q4
$8.77M Sell
31,759
-1,347
-4% -$341K 2.23% 7
2021
Q3
$7.65M Sell
33,106
-137
-0.4% -$33.8K 2.06% 9
2021
Q2
$7.63M Sell
33,243
-305
-0.9% -$61.3K 2.04% 8
2021
Q1
$6.06M Sell
33,548
-312
-0.9% -$61K 1.69% 12
2020
Q4
$5.72M Sell
33,860
-50
-0.1% -$7.46K 1.78% 9
2020
Q3
$5.02M Sell
33,910
-1,871
-5% -$290K 1.8% 11
2020
Q2
$5.87M Sell
35,781
-51
-0.1% -$7.83K 2.17% 7
2020
Q1
$4.97M Sell
35,832
-1,273
-3% -$175K 2.54% 6
2019
Q4
$4.88M Buy
+37,105
New +$4.3M 1.51% 11

Other funds holding LLY

SkyOak Wealth's LLY Position: Q2 2026 in Review

SkyOak Wealth increased its Eli Lilly (LLY) stake by 0.67% in Q2 2026, buying an estimated $111K and bringing the position to 16,314 shares worth $19.6M. The position accounts for 3.2% of the portfolio, ranked #8.

SkyOak Wealth first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SkyOak Wealth held 16,314 shares of Eli Lilly worth $19.6M as of Q2 2026.
  • SkyOak Wealth bought 109 Eli Lilly shares in Q2 2026, an estimated $111K.
  • Eli Lilly made up 3.2% of SkyOak Wealth's portfolio in Q2 2026, its #8 holding.
  • SkyOak Wealth first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SkyOak Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.